Maxicure

#Healthcare #Industrials/Manufacturing #Pharmaceuticals/OTC
ProHub Comment

This is a well-structured operational case requiring candidates to evaluate make/buy decisions with quantitative analysis. The case tests framework development, financial modeling (break-even analysis at 110M units), and business judgment across three increasingly complex questions.

Estimated Time 26 minutes
Difficulty Medium
Source Darden
40 / 100
Your client, Maxicure, manufactures and sells an over-the-counter cough and cold medicine. Their sole plant in Kentucky is aging, and its increasing maintenance costs are leading to low margins on their products. How would you advise Maxicure proceed to solve this problem?

Clarifying Information

  1. There are 2-3 larger players in this over-the-counter business who have distribution across the country. Maxicure is one of them.
  2. Maxicure sells all of its products in the US
  3. Objective is to reduce production costs while maintaining product quality (cost, quality and brand image all matter to customers).
Mock Interview
Interviewer

Your client, Maxicure, manufactures and sells an over-the-counter cough and cold medicine. Their sole plant in Kentucky is aging, and its increasing maintenance costs are leading to low margins on their products. How would you advise Maxicure proceed to solve this problem?

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

Maxicure faces declining profitability due to aging manufacturing infrastructure. The case guides candidates through option evaluation, break-even analysis comparing in-house production versus outsourcing, and negotiation strategy for state incentives.

Key Insights:

  1. Build vs. buy decisions require comprehensive cost-benefit analysis including both financial and strategic factors
  2. Break-even analysis at 110M units demonstrates outsourcing is only cheaper below this volume threshold; in-house investment becomes profitable above it
  3. Successful conclusion requires synthesizing quantitative findings with qualitative risk assessment and stakeholder considerations